Of note, the serum level of RBP4 showed no statistically different between patients with pancreatic adenocarcinoma or chronic pancreatitis, indicating it may not be a suitable biomarker for pancreatic cancer [8]. Here, RBP4 is linked to pancreatic neoplasm.